Mutation of a single residue promotes gating of vertebrate and invertebrate two-pore domain potassium channels.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
15 02 2019
Historique:
received: 16 07 2018
accepted: 23 01 2019
entrez: 17 2 2019
pubmed: 17 2 2019
medline: 9 4 2019
Statut: epublish

Résumé

Mutations that modulate the activity of ion channels are essential tools to understand the biophysical determinants that control their gating. Here, we reveal the conserved role played by a single amino acid position (TM2.6) located in the second transmembrane domain of two-pore domain potassium (K2P) channels. Mutations of TM2.6 to aspartate or asparagine increase channel activity for all vertebrate K2P channels. Using two-electrode voltage-clamp and single-channel recording techniques, we find that mutation of TM2.6 promotes channel gating via the selectivity filter gate and increases single channel open probability. Furthermore, channel gating can be progressively tuned by using different amino acid substitutions. Finally, we show that the role of TM2.6 was conserved during evolution by rationally designing gain-of-function mutations in four Caenorhabditis elegans K2P channels using CRISPR/Cas9 gene editing. This study thus describes a simple and powerful strategy to systematically manipulate the activity of an entire family of potassium channels.

Identifiants

pubmed: 30770809
doi: 10.1038/s41467-019-08710-3
pii: 10.1038/s41467-019-08710-3
pmc: PMC6377628
doi:

Substances chimiques

Caenorhabditis elegans Proteins 0
Potassium Channels, Tandem Pore Domain 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

787

Subventions

Organisme : NIH HHS
ID : P40 OD010440
Pays : United States

Références

Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14628-33
pubmed: 19667202
Elife. 2012 Dec 13;1:e00184
pubmed: 23240087
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18590-5
pubmed: 19020092
Nature. 2014 Dec 4;516(7529):126-30
pubmed: 25471887
Science. 2015 Mar 13;347(6227):1256-9
pubmed: 25766236
WormBook. 2013 Aug 13;:1-106
pubmed: 24081909
Science. 2012 Jan 27;335(6067):432-6
pubmed: 22282804
Structure. 2017 May 2;25(5):708-718.e2
pubmed: 28392258
EMBO Mol Med. 2014 Jun 27;6(7):937-51
pubmed: 24972929
Cell. 2016 Feb 25;164(5):937-49
pubmed: 26919430
J Physiol. 2007 Aug 15;583(Pt 1):57-69
pubmed: 17540699
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5499-504
pubmed: 22431633
Physiology (Bethesda). 2011 Dec;26(6):424-37
pubmed: 22170960
EMBO J. 2011 Aug 05;30(17):3607-19
pubmed: 21822218
Neuron. 2014 Dec 17;84(6):1198-212
pubmed: 25500157
J Pharmacol Exp Ther. 2003 Jul;306(1):84-92
pubmed: 12660311
Neuron. 2005 Sep 15;47(6):833-43
pubmed: 16157278
EMBO J. 1998 Jun 15;17(12):3297-308
pubmed: 9628867
J Mol Biol. 2015 Jan 16;427(1):121-30
pubmed: 25106689
Nature. 1995 Aug 24;376(6542):690-5
pubmed: 7651518
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7063-8
pubmed: 12740433
J Biol Chem. 2008 Jul 11;283(28):19448-55
pubmed: 18474599
Nat Rev Neurosci. 2007 Apr;8(4):251-61
pubmed: 17375039
Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):666-71
pubmed: 17197424
J Neurosci. 2003 Oct 8;23(27):9133-45
pubmed: 14534247
Nat Commun. 2014 Jul 08;5:4377
pubmed: 25001086
J Neurosci. 2000 Oct 15;20(20):7517-24
pubmed: 11027209
Am J Hum Genet. 2018 Oct 4;103(4):621-630
pubmed: 30290154
J Membr Biol. 2006 Mar;210(1):51-70
pubmed: 16794780
Physiol Rev. 2010 Apr;90(2):559-605
pubmed: 20393194
Biophys J. 1999 Oct;77(4):1960-72
pubmed: 10512816
J Physiol. 2004 Jan 1;554(Pt 1):64-77
pubmed: 14678492
Science. 2012 Jan 27;335(6067):436-41
pubmed: 22282805
Sci Rep. 2017 Apr 5;7(1):649
pubmed: 28381826
Nat Struct Mol Biol. 2009 Jan;16(1):71-9
pubmed: 19098918
PLoS Genet. 2014 Feb 20;10(2):e1004175
pubmed: 24586202
EMBO J. 2011 Jul 15;30(17):3594-606
pubmed: 21765396
Neuron. 2001 Nov 20;32(4):635-48
pubmed: 11719204
J Mol Biol. 2011 Aug 5;411(1):27-35
pubmed: 21554888
Genetics. 1982 Jun;101(2):211-25
pubmed: 7173602
J Biol Chem. 1998 Nov 20;273(47):30863-9
pubmed: 9812978
Genetics. 1974 May;77(1):71-94
pubmed: 4366476
Genome Res. 2004 Jun;14(6):1188-90
pubmed: 15173120
J Physiol Biochem. 2015 Dec;71(4):601-10
pubmed: 26271386
G3 (Bethesda). 2017 May 5;7(5):1429-1437
pubmed: 28280211
J Biol Chem. 2011 Nov 18;286(46):39813-22
pubmed: 21965685
Trends Pharmacol Sci. 2005 Jul;26(7):361-7
pubmed: 15939489
Curr Top Membr. 2014;74:113-33
pubmed: 25366235
J Biol Chem. 2013 Dec 6;288(49):35081-92
pubmed: 24163367
EMBO J. 2012 Aug 1;31(15):3297-308
pubmed: 22728824
Nature. 2017 Jul 20;547(7663):364-368
pubmed: 28693035
ACS Chem Biol. 2013 Aug 16;8(8):1841-51
pubmed: 23738709
Diabetes. 2015 Nov;64(11):3818-28
pubmed: 26239056

Auteurs

Ismail Ben Soussia (I)

Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Lyon, 69008, France.

Sonia El Mouridi (S)

Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Lyon, 69008, France.

Dawon Kang (D)

Department of Physiology, College of Medicine and Institute of Health Sciences, Gyeongsang National University, Jinju, 52727, South Korea.

Alice Leclercq-Blondel (A)

Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Lyon, 69008, France.

Lamyaa Khoubza (L)

Institut de Pharmacologie Moléculaire et Cellulaire, LabEx ICST, CNRS UMR 7275, Université de Nice Sophia Antipolis, Valbonne, 06560, France.

Philippe Tardy (P)

Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Lyon, 69008, France.

Nora Zariohi (N)

Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Lyon, 69008, France.

Marie Gendrel (M)

Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Lyon, 69008, France.

Florian Lesage (F)

Institut de Pharmacologie Moléculaire et Cellulaire, LabEx ICST, CNRS UMR 7275, Université de Nice Sophia Antipolis, Valbonne, 06560, France.

Eun-Jin Kim (EJ)

Department of Physiology, College of Medicine and Institute of Health Sciences, Gyeongsang National University, Jinju, 52727, South Korea.

Delphine Bichet (D)

Institut de Pharmacologie Moléculaire et Cellulaire, LabEx ICST, CNRS UMR 7275, Université de Nice Sophia Antipolis, Valbonne, 06560, France.

Olga Andrini (O)

Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Lyon, 69008, France. olga.andrini@univ-lyon1.fr.

Thomas Boulin (T)

Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR 5310, INSERM U1217, Lyon, 69008, France. thomas.boulin@univ-lyon1.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH